Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/15/2007


1.		Phase I/II Study of CI-980 for Recurrent or Progressive Malignant Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				MDA-NCNSC-95003 NCI-T95-0101O, T95-0101

Last Modified: 9/1/2000


2.		Phase I/II Study of CI-980 for Newly Diagnosed Malignant Glioma (Summary Last Modified 09/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				over 18				NCI				NABTT-9602 JHOC-NABTT-9602, NCI-T96-0027H

Last Modified: 7/1/1998


3.		Phase II Study of CI-980 for Advanced Soft Tissue Sarcomas (Summary Last Modified 07/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				MDA-DM-95217 NCI-T95-0102H, T95-0102

Last Modified: 6/1/1999


4.		Phase II Study of CI-980 in Metastatic Malignant Melanoma (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				adult				NCI				SWOG-S9622 SWOG-9622, S9622

Last Modified: 1/1/1998


5.		Phase II Study of CI-980 for Advanced non-Small Cell Lung Cancer (Summary Last Modified 01/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-8182 NCI-T96-0008H, T96-0008

Last Modified: 8/1/1999


6.		Phase II Study of CI-980 for Advanced Melanoma (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-8183 NCI-T96-0007H, T96-0007

Last Modified: 8/1/1999


7.		Phase II Study of CI-980 for Hormone-Refractory Stage D2 Prostate Cancer (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-8254 NCI-T96-0048H, T96-0048

Last Modified: 9/1/1999


8.		Phase II Study of CI-980 in Untreated Extensive Stage Small Cell Lung Cancer (Summary Last Modified 09/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				OSU-9614 OSU-T96-9614, NCI-T96-0020H, T96-0020

Last Modified: 4/1/1998


9.		Phase II Trial of CI-980 in Advanced Renal Cell Carcinoma (Summary Last Modified 04/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-8184 NCI-T96-0006H, T96-0006

Last Modified: 2/1/1995


10.		Phase I Study of CI-980 as a 72-Hour Infusion with and without G-CSF for Advanced Solid Tumors (Summary Last Modified 02/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 18				NCI				JHOC-T93-0186 NCI-T93-0186D, T93-0186

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute